Market Overview:
The global PCR test market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of infectious diseases, cancer, and cardiovascular diseases; rising demand for personalized medicine; and technological advancements in PCR testing. In terms of type, the infectious disease segment accounted for the largest share of the global PCR test market in 2017. This segment is expected to grow at a CAGR of 11% from 2018 to 2030 due to the increasing incidence of infectious diseases across the globe. The cancer segment is projected to grow at a CAGR of 11% from 2018 to 2030 due to rising incidences of cancer and growing demand for early diagnosis and treatment options.
Product Definition:
The polymerase chain reaction (PCR) is a laboratory technique used to amplify a specific region of DNA. The PCR test is used to detect the presence of a particular gene or sequence of DNA in a sample. The importance of the PCR test is that it can be used to identify small amounts of DNA, making it useful for diagnosing genetic diseases and other medical conditions.
Infectious Disease:
Infectious disease is the medical condition caused by pathogens, which are infectious agents that cause diseases in animals and humans.
This market is segmented on the basis of technology used for detection such as Polymerase Chain Reaction (PCR) test, monoclonal antibodies, microarrays and other technologies like flow cytometry & immunoassay.
Cancer:
The global cancer and it's usage in PCR test market size was valued at USD 6.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of cancer worldwide, coupled with rising demand for early diagnostic tests, is anticipated to drive growth during the forecast period.
Application Insights:
The hospitals segment dominated the market in 2017 and is expected to maintain its dominance over the forecast period. This can be attributed to factors such as increasing healthcare spending, growing geriatric population, and favorable government policies. The others application segment includes research settings and private practices. Increasing adoption of PCR for detection of infectious diseases is expected to drive this application in clinics and other settings, thereby contributing toward revenue growth during the forecast period.
Increasing prevalence of chronic diseases such as cancer, cardiovascular disorders & diabetes mellitus are anticipated to boost demand for PCR tests during the forecast period1). For instance, according these statistics published by WHO in 2018 regarding cancer cases worldwide; it was estimated that around 1 million new cases were diagnosed with lung cancer annually along with about 80 thousand new cases for colorectal cancers2). Thus increasing number of patients suffering from these conditions will contribute toward revenue generation during the projected time frame.
Regional Analysis:
North America dominated the global PCR test market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing demand for advanced diagnostic procedures are some of the factors responsible for its large share. In addition, North America is home to several major market players such as Thermo Fisher Scientific Inc.; Roche; Amgen; Pfizer Inc.; and Abbott that are constantly investing in R&D activities to develop novel products with improved sensitivity and specificity.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income levels coupled with growing awareness about early diagnosis among patients. Moreover, an increase in government initiatives aimed at improving public health infrastructure will also contribute towards regional growth over the next eight years. For instance, according to a 2016 article published by NCBI (National Center for Biotechnology Information), Japan has one of Asia's highest life expectancies at 81 years (in 2015).
Growth Factors:
- Increasing demand for PCR tests for early diagnosis of diseases
- Rising prevalence of infectious diseases
- Technological advancements in PCR testing methods
- Growing demand for personalized medicine
- Increasing number of public and private sector initiatives to promote use of PCR tests
Scope Of The Report
Report Attributes
Report Details
Report Title
PCR Test Market Research Report
By Type
Infectious Disease, Cancer, Cardiovascular, Genetic, Others
By Application
Hospitals, Clinics, Others
By Companies
Abbott Laboratories, Agilent Technologies Inc., Abbott, Asuragen, Inc., Danaher, Biocartis Group Nv, Biomérieux, Bio-Rad Laboratories, Inc., Genmark Diagnostics, Inc., Hologic, Inc., Luminex Corporation, Meridian Bioscience, Inc., Qiagen N.V., Quantumdx Group, Quidel, Inc., Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global PCR Test Market Report Segments:
The global PCR Test market is segmented on the basis of:
Types
Infectious Disease, Cancer, Cardiovascular, Genetic, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Agilent Technologies Inc.
- Abbott
- Asuragen, Inc.
- Danaher
- Biocartis Group Nv
- Biomérieux
- Bio-Rad Laboratories, Inc.
- Genmark Diagnostics, Inc.
- Hologic, Inc.
- Luminex Corporation
- Meridian Bioscience, Inc.
- Qiagen N.V.
- Quantumdx Group
- Quidel, Inc.
- Roche
Highlights of The PCR Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Infectious Disease
- Cancer
- Cardiovascular
- Genetic
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the PCR Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
PCR Test is a laboratory test that helps identify the presence of specific DNA sequences in a sample. PCR is an abbreviation for polymerase chain reaction, which is a technique used to copy and amplify pieces of DNA.
Some of the key players operating in the pcr test market are Abbott Laboratories, Agilent Technologies Inc., Abbott, Asuragen, Inc., Danaher, Biocartis Group Nv, Biom©rieux, Bio-Rad Laboratories, Inc., Genmark Diagnostics, Inc., Hologic, Inc., Luminex Corporation, Meridian Bioscience, Inc., Qiagen N.V., Quantumdx Group, Quidel, Inc., Roche.
The pcr test market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 PCR Test Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 PCR Test Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 PCR Test Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the PCR Test Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global PCR Test Market Size & Forecast, 2018-2028
4.5.1 PCR Test Market Size and Y-o-Y Growth
4.5.2 PCR Test Market Absolute $ Opportunity
Chapter 5 Global PCR Test Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 PCR Test Market Size Forecast by Type
5.2.1 Infectious Disease
5.2.2 Cancer
5.2.3 Cardiovascular
5.2.4 Genetic
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global PCR Test Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 PCR Test Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global PCR Test Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 PCR Test Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America PCR Test Analysis and Forecast
9.1 Introduction
9.2 North America PCR Test Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America PCR Test Market Size Forecast by Type
9.6.1 Infectious Disease
9.6.2 Cancer
9.6.3 Cardiovascular
9.6.4 Genetic
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America PCR Test Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe PCR Test Analysis and Forecast
10.1 Introduction
10.2 Europe PCR Test Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe PCR Test Market Size Forecast by Type
10.6.1 Infectious Disease
10.6.2 Cancer
10.6.3 Cardiovascular
10.6.4 Genetic
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe PCR Test Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific PCR Test Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific PCR Test Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific PCR Test Market Size Forecast by Type
11.6.1 Infectious Disease
11.6.2 Cancer
11.6.3 Cardiovascular
11.6.4 Genetic
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific PCR Test Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America PCR Test Analysis and Forecast
12.1 Introduction
12.2 Latin America PCR Test Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America PCR Test Market Size Forecast by Type
12.6.1 Infectious Disease
12.6.2 Cancer
12.6.3 Cardiovascular
12.6.4 Genetic
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America PCR Test Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) PCR Test Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) PCR Test Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) PCR Test Market Size Forecast by Type
13.6.1 Infectious Disease
13.6.2 Cancer
13.6.3 Cardiovascular
13.6.4 Genetic
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) PCR Test Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 PCR Test Market: Competitive Dashboard
14.2 Global PCR Test Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Agilent Technologies Inc.
14.3.3 Abbott
14.3.4 Asuragen, Inc.
14.3.5 Danaher
14.3.6 Biocartis Group Nv
14.3.7 Biomérieux
14.3.8 Bio-Rad Laboratories, Inc.
14.3.9 Genmark Diagnostics, Inc.
14.3.10 Hologic, Inc.
14.3.11 Luminex Corporation
14.3.12 Meridian Bioscience, Inc.
14.3.13 Qiagen N.V.
14.3.14 Quantumdx Group
14.3.15 Quidel, Inc.
14.3.16 Roche
